Current Projects
Search
 

Home
Search for Projects
View Projects
Project Title
by Subject/Focus Area
by Board/Committee
by Major Unit
Provisional Committee Appointments Open for Formal Public Comments
by Last Update
Meeting Information
Conflict of Interest Policy
Committee Appointment Process
FAQ
  meetingview
More Project Information and to provide FEEDBACK on the Project

 Printer Friendly Version


Meeting Information



Project Title: A National Strategy for the Elimination of Hepatitis B and C

PIN: IOM-BPH-15-07         

Major Unit:
Institute of Medicine

Sub Unit:
Board on Population Health and Public Health Practice

RSO:
Buckley, Gillian

Subject/Focus Area:
Health and Medicine


A National Strategy for the Elimination of Hepatitis B and C, Meeting 1
November 30, 2015 - December 1, 2015
Keck Center
500 5th Street, NW
Washington D.C. 20001



If you would like to attend the sessions of this meeting that are open
to the public or need more information please contact:


Contact Name: Hope Hare
Email: hhare@nas.edu
Phone: 202-334-3435
Fax:


Agenda:

COMMITTEE ON A NATIONAL STRATEGY FOR THE ELIMINATION OF HEPATITIS B AND C
The Keck Center, 500 Fifth Street NW
Washington DC 20001

NOVEMBER 30, 2015
ROOM 105

SESSION 1- CLOSED

SESSION 2- OPEN
THE CHARGE TO THE COMMITTEE AND PHASE 1 REPORT

10:45-11:30 The Charge to the Committee
John Ward, Director, Office of Viral Hepatitis, CDC
Nadine Gracia, DDeputy Assistant Secretary for Minority Health and Director, Office of Minority Health, HHS

11:30-12:00 Study Timeline
Brian Strom, Committee Chair

12:00-1:00 Lunch

SESSION 3- OPEN
OVERVIEW OF HBV & LOGISTICAL AND SOCIAL ASPECTS OF ELIMINATION

1:00-1:30 Overview of Epidemiology and Natural History of Hepatitis B
Jules Dienstag, Carl W. Walter Professor Medicine, Massachusetts General Hospital

1:30-2:00 Gaps in Hepatitis B Monitoring and Screening
Mandana Khalili, Professor of Clinical Medicine, UCSF

2:00-2:30 The Costs and Logistics of Community HBV Screening Programs
Chari Cohen, Director of Public Health, Hepatitis B Foundation

2:30-2:45 Break

2:45-3:15 The Health Systems Obstacles to Hepatitis B Elimination
Robert Gish, Principal, Robert Gish Consultants, LLC

3:15-3:45 Management of the Chronic Hepatitis B Patient in Alaska
Brian McMahon, Medical and Research Director, Alaska Native Tribal Health Consortium (by video)

3:45-5:00 Panel Discussion Social and Logistical Feasibility of Eliminating HBV
Art Reingold, Moderator
Chari Cohen, Director of Public Health, Hepatitis B Foundation
Jules Dienstag, Carl W. Walter Professor Medicine, Massachusetts General Hospital
Adrian DiBesceglie, Co-Director, Saint Louis University Liver Center (by phone)
Robert Gish, Principal, Robert Gish Consultants, LLC
Brian McMahon, Medical and Research Director, Alaska Native Tribal Health Consortium (by video)
5:15 Adjourn

December 1, 2015

SCIENTIFIC AND MEDICAL ASPECTS OF ELIMINATION

9:00-9:15 Welcome and Meeting Overview
Brian Strom, Committee Chair

9:15-9:45 Medical Management of Hepatitis B
Anna Lok, Alice Lohrman Andrews Research Professor, University of Michigan Health System

9:45-10:15 Hep B Reactivation
Rohit Loomba, Professor of Medicine, UCSD

10:15-10:30Break

10:30-11:00 Immunology of Hepatitis B
Kyong-Mi Chang, Associate Chief of Staff for Research and Development, Corporal Michael J. Crescenz VA Medical Center

11:00-11:30 Virology of Hepatitis B
T. Jake Liang, Chief of Liver Diseases Branch, Deputy Director of Translational Research, NIDDK, NIH

11:30-12:30 Panel Discussion Scientific and Clinical Feasibility of Eliminating HBV
Randy Mayer, Moderator
Kyong-Mi Chang, Associate Chief of Staff for Research and Development, Corporal Michael J. Crescenz VA Medical Center
T. Jake Liang, Chief of Liver Diseases Branch, Deputy Director of Translational Research, NIDDK, NIH
Anna Lok, Alice Lohrman Andrews Research Professor, University of Michigan Health System: brief comment on the changing epidemiolgoy
Rohit Loomba, Professor of Medicine, UCSD


Closed Session Summary Posted After the Meeting

The following committee members were present at the closed sessions of the meeting:
Brian Storm
Jon Andrus
Daniel Church
Alison Evans
Paul Kuehnert
Vincent Lo Re
Kathleen Maurer
Randall Mayer
Stuart Ray
Arthur Reingold
Samuel So
Grace Wang
Lucy Wilson

The following topics were discussed in the closed sessions:
Phase 1

The following materials (written documents) were made available to the committee in the closed sessions:
Briefing book, articles

Date of posting of Closed Session Summary: December 9, 2015